What the market is telling us: Recurring themes from life science events in 2026

Back in March, after a run of life science events spanning biologics, outsourcing and pharma services, we shared some of the recurring conversations our team was hearing across the market.

A few months (and a few more very sore feet) later, our BD team have been back out again – this time at mRNA Boston, CDMO Live, TIDES and Interphex – continuing to gather the kind of cross-market intel you only really get by being in the room.

Interestingly, many of the same themes are becoming louder.

Different events. Different audiences. Different technologies. But the same commercial pressures keep surfacing across conversations with CDMOs, CROs, biotech companies, suppliers and technology providers alike.

Here are the biggest themes we’re seeing emerge across the life science event market right now, and what they mean from a brand and commercial perspective.

1. Scientific complexity is becoming a commercial challenge

Across mRNA Boston especially, one thing became impossible to ignore: the science is accelerating rapidly.

RNA therapeutics. Circular RNA. AI-enabled bioprocessing. Novel delivery systems. Advanced manufacturing technologies. The innovation happening across life sciences is hugely exciting.

But there’s an emerging challenge sitting underneath all of it – many companies are becoming harder to understand. 

That matters more than people think; while scientific audiences may appreciate technical detail, commercial audiences like investors, procurement teams and even potential hires often need clarity first.

If people can’t quickly understand:

• What makes a company different
• Why the science matters
• Where the commercial value sits

…even strong innovation risks getting lost in the noise.

The companies standing out most right now aren’t necessarily simplifying the science itself, but simplifying the explanation.

What this means for brands

Clear positioning is becoming a competitive advantage.

The companies winning attention are increasingly the ones translating technical complexity into:

• Commercial relevance
• Real-world impact
• Confidence and clarity

2. The AI conversation is shifting from hype to reality

AI was everywhere (no surprise there), but what was interesting was how conversations around AI have matured compared to even six or twelve months ago.

The loudest conversations weren’t really about futuristic possibilities anymore; instead, people are asking about:

• Implementation
• Data quality
• Operational integration
• Internal adoption
• Proving ROI
• Reducing friction

In other words, it’s less about “AI will change everything,” and more about “How do we actually make this useful?”

In our eyes, that’s a healthy shift that is long overdue – buyers are becoming more sceptical of vague AI messaging. People want practical applications, not just shiny positioning statements attached to existing platforms.

One attendee described it perfectly:
“Everyone’s selling AI. Very few are selling operational reality.”

We’re definitely seeing that too across the sector.

What this means for brands

The strongest positioning in AI-enabled life sciences right now feels:

• Practical
• Grounded
• Commercially aware
• Operationally credible

The companies building trust are the ones focusing on outcomes and implementation, not just innovation.

3. Event-led marketing strategies are under pressure

This theme came up repeatedly at Interphex; face-to-face conversations and industry visibility still matters, but there’s growing pressure around how event investment is justified internally.

A lot of companies are asking:

• What are we actually getting from this?
• How does this contribute to the pipeline?
• Are we too reliant on conferences?
• What happens between events?

At the same time, many marketing teams remain incredibly lean. In several conversations, companies described:

• One-person marketing teams
• Fragmented responsibilities across regions or subsidiaries
• Limited internal strategy support
• Reactive campaign planning
• Pressure to prove ROI quickly

That combination is creating strain, because buyers don’t suddenly stop researching the moment an event ends. They’re consuming content year-round, comparing suppliers continuously and forming opinions before sales conversations ever happen.

What this means for brands

The ‘event-only growth strategy’ is starting to creak. We’re now seeing much more interest in always-on visibility and long-term brand building across thought leadership, digital campaigns, PR and more. 

This approach isn’t instead of events, but around them. The companies gaining traction are increasingly treating events as one touchpoint within a broader commercial strategy, not the entire strategy itself.

4. Technical capability alone is becoming harder to differentiate

A few years ago, simply having a specialist capability often helped companies stand out. Today, many businesses across the whole supply chain are saying very similar things.

Everyone has quality outputs, innovative offerings and experienced teams, which are, of course, great things to promote, but the issue is they’ve become expected.

Which means differentiation is becoming less about capabilities alone and more about building trust through how your brand is positioned and telling a story that potential customers want to buy into.

The strongest companies are getting much clearer about:

• Problems they solve
• Outcomes they create
• Risks they reduce
• The value they unlock

What this means for brands

Messaging is shifting away from “Here’s what we do” toward “Here’s why it matters.”

That’s a subtle shift, but a commercially imperative one.

5. The market feels more intentional than ever

Across almost every conversation, there’s a sense that the industry has become sharper. Not negative or ‘cautiously optimistic,’ just more considered.

There’s:

• Tighter scrutiny around budgets
• More pressure on timelines
• Increased focus on efficiency
• More questions around ROI
• Greater awareness of risk

Funding pressure and regulatory uncertainty are clearly influencing decision-making. But interestingly, this caution is also creating opportunities for companies with strong positioning and clear market narratives.

When buyers become more selective, things like trust, clarity and confidence matter even more.

What this means for brands

The companies that stand out over the next few years probably won’t be the loudest. They’ll be the clearest in their 

• Positioning and messaging
• Commercial value
• Market relevance

6. Manufacturing resilience is becoming part of the value proposition

Another theme surfacing repeatedly across conversations was the growing importance of regional manufacturing resilience and supply chain security.
While operational reliability has always mattered in outsourcing, companies are now talking much more openly about:

• US and EU manufacturing footprints
• Dual sourcing strategies
• Regional redundancy
• Geopolitical risk mitigation
• Supply chain security and continuity

What’s interesting is that this is no longer being positioned purely as an operational conversation. Increasingly, it’s becoming part of commercial positioning and buyer confidence too. As procurement and supply chain teams become more commercially strategic, resilience itself is starting to influence differentiation.

What this means for brands

Operational strength alone isn’t enough if the market can’t clearly see or understand it. The companies building confidence most effectively are increasingly the ones communicating:

• Stability and reliability
• Strategic manufacturing footprint
• Supply chain confidence
• Long-term partnership readiness

The value of cross-market visibility

One of the most interesting parts of attending life science events across multiple sub-sectors is seeing how often the same pressures emerge in completely different environments.

The technology and audience may differ, but the underlying commercial conversations are increasingly connected.

That cross-market visibility matters because it helps identify broader industry shifts earlier before they hit the mainstream.